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ABSTRACT 
 
Typically, a Parkinson’s disease (PD) patient would display instances of tremor and 
bradykinesia (slowness of movement) at an early stage of the disease and later develop gait 
disturbances and postural instability. So, it is important to measure the tremor occurrences in 
subjects to detect the onset of PD. Also, it is equally essential to monitor the gait impairments that 
the patient displays, as the order at which the PD symptoms appear in subjects vary from one to 
another.   
The primary goal of this thesis is to develop a monitoring system for PD patients using 
wearable sensors.  To achieve that objective, our work focused first on identifying the most 
significant features that would best distinguish between PD and normal healthy subjects.  Here, 
the various gait and tremor features were extracted from the raw data collected from the wearable 
sensors and further analyzed using statistical analysis and pattern classification techniques to pick 
the most significant features. In statistical analysis, the analysis of variance (ANOVA) test was 
conducted to differentiate the subjects based on the values of the mean. Further, pattern 
classification was carried out using the Linear Discriminant Analysis (LDA) algorithm. The 
analysis of our results shows that the features of heel force, step distance, stance and swing phases 
contributed more significantly to achieving a better classification between a PD and a normal 
subject, in comparison with other features. Moreover, the tremor analysis based on the frequency-
domain characteristics of the signal including amplitude, power distribution, frequency dispersion, 
and median frequency was carried out to identify PD tremor from different types of artifacts.  
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CHAPTER 1: 
INTRODUCTION 
 
1.1 Background and Motivation 
 Computers and electronics have become an integral part of the biomedical signal analysis, 
aiding from data acquisition to signal processing stages. Also, the introduction of wearable sensors 
has changed the way we acquire, record and monitor the bio-signals.  Numerous products ranging 
from those that improve the standard of living to monitoring body’s vital signs (body temperature, 
pulse rate, blood pressure, and respiration rate) have been revolutionizing the health care industry. 
Moreover, with the stepping of tech giants such as Apple, Samsung, Google and others into the 
world of wearable, it could denote the importance of wearable technologies in improving the 
quality of life of people.  
 Earlier, to monitor a person’s ECG, an instrument specifically designed to measure the 
heart’s activity with a monitor to display the readings would be essential. Nowadays, a wearable 
sensor provide us with advantages such as the wireless connectivity, lightweight, and low power 
consumption. Also, the sensors are multi-dimensional in its purpose, which implies that a single 
sensor could be used to measure the heart’s activity, blood pressure, and also the muscle activity 
simultaneously [1]. However, its reliability and performance over a period of time are not 
satisfactory.  
 Biomedical signal processing has also seen some significant changes over time. Earlier, it 
was mainly concentrated on removing artifacts, spectral analysis and modelling for signal feature                      
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representation. Recent trends have been toward quantitative or objective analysis of bio-signals. 
Also, advancements in the practical application of signal processing (digital filter designing, peak 
detection, feature extraction from signals, and frequency-domain analysis ) and machine learning 
algorithms have provided us an efficient and reliable method for diagnosis, monitoring, and 
rehabilitation of patients [2-4]. Moreover, these techniques are widely accepted by clinicians and 
have strengthened the role of engineering in clinical studies. 
 Figure 1.1 presents wearable sensors that measure the bio-signals from different parts of 
the human body. All the sensors are connected to a central hub, which acts as a transceiver that 
connects to a computer through wireless connectivity. Also, it can simultaneously send the 
measured value from the sensors to the system. 
ECG sensor 
Accelerometer  
Blood pressure 
sensor 
Force sensor 
Figure 1.1. Wearable sensors placed at different parts of the body. Adapted from “clker.com” by 
OCAL, 2012, CC0 public domain. 
Wireless 
transceiver 
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1.2 Parkinson’s Disease: An Overview   
Parkinson’s disease (PD) is ranked the second most common neurodegenerative disease 
next to Alzheimer’s disease. As identified by Parkinson Disease Foundation [5], nearly 1 million 
people suffer from PD in the USA alone, and this raises to around 7 to 10 million cases worldwide. 
PD stands 14th as the most common cause of death in the USA. Deterioration of dopamine-
producing neurons in the brain is the primary cause of PD, where Dopamine is an essential 
neurotransmitter that controls both smooth and coordinated muscle function [5].  
The main motor symptoms of PD include tremor at rest, bradykinesia, rigidity, and 
impairment of postural balance [6]. Resting tremor is a common symptom at an early stage of PD, 
and it can be seen in 70% of patients approximately. Typically, it occurs at a frequency of 4-6 Hz 
causing a ‘pill rolling’ movement of the thumb and index finger. The tremor may also extend to 
the forearm or even to the elbow and upper arm. Additionally, PD patients also display slowness 
in performing voluntary movements called as bradykinesia, during the onset of PD. Rigidity is the 
resistance to passive stretch, and postural instability causes the person to have trouble in walking, 
turning and balance [6].  
Further, postural instability causes instances of freezing of gait (FOG) [7], which is defined 
as a period where the person would hesitate to move forward or make turns despite the intention 
to move. The FOG and falls are closely associated with each other, as the PD subjects might 
experience fall, when they face trouble in maintaining the balance while turning or changing 
directions. As the FOG episodes are unpredictable, it is also difficult to prevent falls and more 
appropriately around 38% of patients with PD experience falls each year [7].   
Additionally, the gait of a PD patient display features such as stooped posture, hesitation 
while walking, slow gait, short steps and reduced arm swing, and can be seen during the later 
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stages of the disease. While, an average person would walk with a straight upright posture, steady 
and evenly matched steps and arms swinging by his sides [8].  
The National Parkinson Foundation claims that typically it requires more than one different 
method to confirm the presence of PD in subjects. Also, to confirm a PD diagnosis, the subject 
must display at least 2 of the 4 main motor symptoms, i.e., resting tremor and bradykinesia. 
Moreover, gait impairments are common in PD patients, who are prone to falls and FOG. It is 
essential to study the differences between a PD and normal gait that leads to postural instability 
and falls. Currently, PD cannot be cured, but its symptoms could be controlled by medications 
and/or by using deep brain stimulation (DBS) treatment [8].  
 
1.3 State of the Art 
 In this section, a detailed review of the various clinical techniques used for diagnosing PD 
is provided. In addition, the different applications of wearable sensor technology in monitoring PD 
symptoms are also discussed. The clinical diagnosis has both its pros and cons, and with the recent 
developments in wearable sensor technology, it could be supplemental in improving the quality of 
life for PD patients. 
 
 1.3.1 Current Diagnosis 
 The diagnosis of PD can be difficult especially in its early stages and at present, there is no 
particular test or biomarker available to diagnose PD. Typically, a neurologist or doctor would 
require the patient’s complete medical history, and also performs numerous clinical assessments 
to confirm on PD presence in that subject. Additionally, various lab tests and imaging techniques 
are used to rule out other conditions that may cause Parkinsonism in subjects, which might not 
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necessarily be due to PD. Moreover, an important diagnostic method includes the subject’s 
response to levodopa therapy. If the subject’s symptoms related to PD, respond well to the 
levodopa therapy then, there is a possibility that the subject might be suffering from PD. However, 
sometimes doctors feel that the intake of medications might be unnecessary during the premature 
stage of the disease [5, 8].  
 Sometimes, it might take up to a year to diagnose PD after careful consideration of the 
subject’s neurological history and clinical assessments. Moreover, there is also a high possibility 
of misdiagnosing PD for other neurological disorders that show parkinsonism.  It has been found 
that the rate of misdiagnosis of PD is around 25%, and approximately 40% of PD cases are 
overlooked for other neurological disorders [5, 8]. Also, it is important to note that the progression 
of symptoms in PD subjects varies from one subject to another. According to experts, the diagnosis 
of PD requires the presence of one or more of the four main PD motor symptoms. It is because the 
progress of PD symptoms varies from one subject to another, for example resting tremor occurs in 
only 70% of PD patients during the onset of the disease. While others might develop gait 
disturbances or even action tremor during their initial stages of PD [5, 8].  So, an early and accurate 
diagnosis of PD is required to treat the patients better and also to control the effects of the 
symptoms more efficiently.  
 
 1.3.2 Literature Review 
Over time, many types of research have evolved on developing a PD monitoring system, 
using different types of sensors, feature sets and analysis methods. Few among the many wearable 
sensors used in acquiring the bio-signals include accelerometers, force sensors, gyroscopes and 
magnetometers [9]. As a result, numerous gait and tremor features are extracted and analyzed to 
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find a better approach to the treatment and management of PD symptoms. Initially, PD patients 
display slowness in performing voluntary movements and tremor at rest, and later develop gait 
disturbances and postural instability. While, it is important to diagnose the onset of PD in subjects 
as early as possible, and also it is equally important to predict falls and aid in the rehabilitation of 
the patients, during the later stages of the disease [10]. For example, Patel et al. [11] worked on 
developing a system that measures the severity of tremor, bradykinesia (slowness of movement) 
and dyskinesia (motor fluctuations) using a wearable sensor platform. Moreover, the results were 
analyzed to obtain the most significant features that could assess the severity of the symptoms and 
dyskinesia reliably. 
Firstly, the resting tremor occurs during the early stage in PD patients, it is essential to 
analyze tremor as the main criterion to diagnose the PD. Several investigators have proposed 
different methods to measure and analyze the tremor in PD patients, and accelerometers are mostly 
used to detect and record PD tremor [12, 13]. The measured tremor intensity could aid in early 
detection of PD, and also for UPDRS (Unified Parkinson’s Disease Rating Scale) correlation. For 
instance, Salarian et al. [14] proposed an algorithm to detect and quantify tremor, and compared 
the measured tremor amplitude to the corresponding UPDRS score. As a result, a high and 
significant correlation was noticed between the amplitude and UPDRS score. Further, Edwards 
and Beuter [15] utilized tremor characteristics such as the amplitude, frequency and spectral power 
to identify PD tremor. Then, they combined the characteristics into a single variable to identify a 
normal from abnormal tremor effectively [15]. Also, PD tremor is characterized by measuring the 
relative power between the frequencies 4-6 Hz.  It is expected that a significant peak occurs in the 
region on a power spectral plot for PD patients. Further, a low amplitude value of physiological 
signal (takes place due to the mechanical reflex and neurogenic oscillations, that are superimposed 
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on the irregular fluctuations in muscle and limb displacements) at the range of 7-12 Hz can also 
be observed [16]. 
On the other hand, it is vital to monitor the gait impairments in patients, to predict falls and 
aid in the rehabilitation process [17, 18]. Recently, gait analysis is being widely used to predict 
falls, UPDRS (Unified Parkinson’s Disease Rating Scale) correlation, and also to study the gait 
patterns of a PD patient in contrast to a normal subject. Also, the variation in gait features enables 
us to group them based on the UPDRS score. In the experiments conducted by Salarian et al. [19], 
they concluded that the stride velocity and stride length of PD patients decreased in comparison to 
normal subjects. Additionally, the stance time in PD patients was higher than that of healthy 
subjects. Conversely, the PD patients demonstrated a lower swing time to a normal subject. 
Additionally, Okuno et al. obtained similar results [20] using a force sensor worn by the subjects. 
Further, Tahir and Manap [21] extracted basic, kinetic and kinematic features based on force 
measurement. Where, basic features include the stride time, walking speed and step length. Next, 
kinetic features include the vertical ground reaction forces (VGRF) at heel and toe contact, and the 
kinematic features include the angle of ankle, knee and hip at heel strike and toe off position.  
Then, through statistical analysis, it was found that step length, walking speed and VGRF were 
among the significant features that would differentiate a PD patient from normal subject [21].  
  Barth et al. [22] examined the gait pattern of normal subjects and PD patients in their 
early and intermediate stages of the disease. The extracted features were classified using different 
types of classifiers, and their individual performances were studied. Among the classifiers used, 
LDA (Linear Discriminant Analysis) provided the best classification accuracy. Further, in [23] 
Frenkel-Toledo et al. studied the relationship between the walking speed and gait variability in PD 
and normal subjects. Also, the investigators had performed statistical analysis (t-test) to compare 
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the two groups. From the achieved results it was evident that the PD patients had an increased 
variability of stride time and swing time as compared to normal subjects.   
From the above literature, very few have performed experiments using both gait and tremor 
analysis to predict the presence of PD as well as to prevent falls. By integrating the gait and tremor 
systems, it could provide us with the tool for early detection and monitoring of PD.  
 
1.4 Research Objectives  
 Patients with Parkinson’s disease (PD) predominantly display resting tremor and slowness 
of voluntary movement (bradykinesia) at an early stage of the disease and later develop gait 
disturbances and postural instability. While it is important to diagnose the onset of PD in subjects 
as early as possible, it is also equally important to aid in their rehabilitation process to improve 
their quality of life. Currently, the diagnosis process is conducted by clinical examination and 
confirmed through dopamine response. It requires a series of assessments over a period of time to 
confirm the presence of PD. The goal of this research is to analyze the features exhibited by PD 
patients during the initial phase of the disease, which would enable us to detect the presence of PD 
at its onset. Also, the focus of this research is on studying the gait disturbances in PD that lead to 
falls and postural instability that has a disastrous impact on the lives of the patients. We had 
performed various analyses using advanced signal processing and machine learning techniques on 
the extracted tremor (amplitude, frequency) and gait parameters (speed, stride time and step 
distance) to compare and distinguish between PD and healthy subjects.  
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1.5 Thesis Organization 
 The thesis is comprised of five chapters. Chapter 1 provides a brief introduction to 
Parkinson’s disease, and further discusses the recent development of PD monitoring systems, with 
the motivation behind this project. In Chapter 2, we have discussed on the various methods used 
for the acquisition of data (gait and tremor) and also, details on the experimental procedure 
followed are included in this chapter. Chapter 3 provides an insight into the feature extraction 
process, which discusses the different types of gait feature to be extracted along with the algorithms 
used in the process. Also, this chapter focuses on the quantification of tremor process including 
the details on the different tremor characteristics is provided. Chapter 4 discusses the various 
statistical and machine learning techniques used on the extracted gait parameters, with the 
classifier performance results. Further, Chapter 4 also explains the tremor analysis process along 
with the analysis results. In Chapter 5, the conclusion and future work of the project are included.
10 
 
CHAPTER 2: 
DATA ACQUISITION METHODS 
 
2.1 Gait in Parkinson’s Disease 
 Firstly, in this study the focus has been on the experiment conducted on patients with 
idiopathic PD (mean age: 66.3 years) with moderate disease severity (H & Y Stage 2–3) and were 
compared to age and gender matched healthy controls. The system consists of a pair of shoes and 
a recording unit. Each shoe contains eight load sensors (Ultraflex Computer Dyno Graphy, 
Infotronic Inc.) that cover the surface of the sole and measure the vertical forces under the foot 
versus time, and the sampling rate for each of these 16 sensors is 100 Hz. The database [24] 
comprises of 3 different experiments conducted by Frenkel-Toledo et al. [23], Hausdorff et al. 
[25], and Yogev et al. [26] which will be discussed in detail below. 
 
 2.1.1 Frenkel-Toledo Group Database (Group ‘Si’) 
 The medical center located at Tel-Aviv, recruited 36 PD patients ranging between 2 & 2.5 
on the Hoehn and Yahr scale (stage of PD). The PD patients were tested against an equally matched 
group of healthy subjects, w.r.t. age and sample population. The subjects were tested under various 
experimental setups and conditions. Our focus was on the walking test conducted on a 35 m (meter) 
walkway, at the subject’s comfortable walking speed for a time period of approximately 2 min.  
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 The gait speed of the participants was determined by measuring the avg. time taken to 
complete 10 m of the total distance. The participant’s age, gender, height and weight were 
collected, and also the Timed Up and Go test was performed to measure the balance and function 
of lower limbs. The investigators collected the subject’s history of falls in the recent year. Also, 
the severity of the disease in PD patients was measured using the Unified Parkinson’s Disease 
Rating Scale (UPDRS). 
 
 2.1.2 Hausdorff and Team Database (Group ‘Ju’) 
   The database consists of recordings from the experiment conducted by Hausdorff and his 
co-investigators, involving 29 PD patients and healthy subjects who had volunteered for this study. 
The PD subjects were selected if they had a mild to moderate disease severity, ranging from 2-3 
on the Hoehn and Yahr scale (H&Y scale). Also, the recruited healthy subjects were verified for 
being free from neurological, visual and gait disturbances. The subjects were tested under various 
conditions, but our interest was to analyze the recordings of subjects walking at their usual and 
comfortable speed. Here, the subjects were instructed to walk for a distance of 100 m on a 
walkway. Later, the force measurements recorded under each foot were analyzed to extract the 
different gait features.   
 
 2.1.3 Yogev and Co. Database (Group ‘Ga’) 
 In this database, clinical trials were conducted using 36 PD patients with a disease severity 
of 2-3 on the H&Y scale, recruited from the Tel-Aviv Sourasky Medical Center. Also, age-
matched 28 healthy subjects had volunteered to participate in the study. The participant’s age, 
gender, height and weight were collected and also the Timed Up and Go test was performed
12 
 
to measure the balance and function of lower limbs. The investigators also collected the subject’s 
history of falls, and measured the severity of the disease in PD patients using the Unified 
Parkinson’s Disease Rating Scale (UPDRS).  
 A series of experiments were conducted by the team, which includes a simple walking task 
to measure the force underneath the foot over a period of time. In which, the subjects were asked 
to walk for a distance of 25 m at their usual and normal pace for a time period of 2 min. Various 
gait features were extracted from the force readings, and the gait speed was calculated by 
measuring the avg. time taken by the subject to complete 8 m of the total distance.  
 
2.2 Tremor Database 
 Beuter and his team [27] investigated the characteristics of rest tremor in PD patients. In 
this study, a group of 16 PD patients, under the age of 70 years were recruited.  Also, the patients 
were under minimum medications at the time of study to induce tremor. The tremor was measured 
using a velocity-transducing laser that is directed at the finger.  Moreover, the scattered light, 
measured in terms of volts is directly proportional to the tremor velocity. The raw output data is 
processed and converted from volts to mm/sec.  
 In this experiment, the subjects were under high-frequency deep brain stimulation (DBS) 
and also were given their medications, except for the initial trial where the subjects had not taken 
their medications for 12 hours and not under DBS treatment (DBS is a surgical procedure to treat 
the various PD symptoms – tremor, rigidity, stiffness and others. A neurotransmitter is surgically 
implanted into patients, and it delivers electrical stimulation to the targeted areas of the brain that 
controls movement).    
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 We used the readings from the initial trial, which is DBS ‘OFF’ and medication ‘OFF’ 
stage so that we could study the instances of tremor in subjects, and also on their involuntary 
movements. The readings were obtained from the Physionet database under a free licensing policy 
[28]. The tremor was recorded for a time period of 60 sec (depending on the duration of tremor 
occurrence in subjects) and sampled at 100 Hz. The output was plotted on a graph, where a positive 
value on the velocity axis denotes a finger extension motion and a negative value corresponds to 
a flexion motion of the finger, which can be seen in Figure 2.1.  
 
 
 
 
 
 
 
                                                                                                                                
 
 
                     
                                                                                                                                          
Extension     
           + 
                   
           - 
Flexion    
            
                   
Figure 2.1.  Representation of the extension and flexion movements of the finger 
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CHAPTER 3: 
FEATURE EXTRACTION  
 
3.1 Introduction 
In this section, the various techniques used to extract features from the force and tremor 
data available are discussed. The classification result entirely depends on how accurate and reliable 
are the features extracted. An algorithm was developed to extract the gait features using the force 
readings obtained from the online database.  
 
3.2 Gait Characteristics 
Here, various types of gait parameters were extracted that would contribute in 
discriminating a PD patient from a normal subject. Several techniques have been used by 
researchers around the globe, to extract numerous gait features. However, the most significant 
features were gathered that would provide a better classification between the two groups. Also, an 
algorithm was coded that runs on a Matlab platform to extract the different gait features.        
 
3.2.1 Different Phases of a Human Gait  
The way a human walk varies from person to person but to perform the act of walking, a 
person must impart enough ground reaction forces using their feet to move forward. Also, a 
periodic change in each foot’s support position is needed to complete a walking step [29]. 
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When a person walks the same cyclic pattern is repeated, which is called as a gait cycle. In 
Figure 3.1, the various stages of a gait cycle are displayed; initially, it begins at the heel strike 
period which also marks the beginning of stance phase. Then, during the midstance period the 
grounded foot passes by the swinging foot.   Later, the stance phase ends at the toe off period, also 
during which the foot accelerates from the ground to enter the swing phase. Further, the foot goes 
into a midswing period where coincidentally it passes by the foot at midstance position.  Finally, 
the swing phase terminates at the next heel strike event, during which the foot decelerates to 
stabilize the foot in an attempt to land the heel.   The stance and swing periods of a normal subject 
varies from that of a PD patient. Usually, PD patients have a reduced swing time and by measuring 
the stance and swing phase of subjects, it could be useful in classifying the PD groups from the 
normal subjects [29]. 
 
 
 
 
 
 
 
Stance phase Swing phase 
Single support phase 
1st Heel strike Toe off 2nd Heel strike Mid stance 
Figure 3.1.  Various stages of a gait cycle are displayed. It begins with the 1st heel strike and ends 
at the next heel strike of the same foot. Reprinted from 
"http://www.wsiat.on.ca/english/mlo/symptoms_leg.htm#back" by Queen's Printer for Ontario, 
2005 
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3.2.2 Distance Measurements 
In Figure 3.2, various distance parameters are displayed, which are useful in studying the 
gait patterns of subjects. The step length is defined as the linear distance in the plane of progression 
between two successive points of foot floor contact of the opposite feet, and the distance between 
two consecutive points of foot contact of the same feet is called as a stride length or a gait cycle.  
Also, step time is the time interval between successive instant of foot floor contact of the opposite 
feet, while cadence is measured by counting the number of steps taken per minute. Additionally, 
walking speed is defined as the distance travelled by the subject per second. The last feature is the 
kinetic feature that mainly focuses on the force acting on the ground during heel and toe contact 
positions [30]. 
 
 
                                                                                                         
  
 3.2.3 Ground Reaction Force (GRF) 
 The GRF is the force imparted by the subject walking, on the floor as a function of time. It 
is measured in Newton (N).  In Figure 3.3, the ground reaction force value of a normal subject 
Stride length (One gait cycle) 
Left step length Right step length 
Figure 3.2. Diagram displaying the step and stride lengths of a gait cycle. Adapted from 
“clker.com” by OCAL, 2010, CC0 public domain 
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from the group ‘Ga’ has been referred to, where the force is plotted against the % of the gait cycle. 
The force rises to 650 N right after the heel strike period and then, drops to 460 N during the 
midstance period. After that, at the toe-off period the force value raises up to 720 N to prepare for 
the swing phase, by gaining enough thrust to push the body forward. Later, during the swing phase 
the force drops to 0 N, where the foot accelerates forward in the air.  
 
 
 
 
 It can be seen from the above plot that two peaks are generated in a gait cycle. The first 
peak occurs when the heel strikes the floor and the second one at the toe-off period, which is 
produced by the push-off force from the ground.  During the early stages of PD, the force values 
for heel contact and toe-off phases are reduced. Also, in the later stages, the force plot is 
characterized by a single and narrow peak [31, 32] as seen in Figure 3.4. It occurs due to the 
Figure 3.3. The vertical ground reaction force acting on a group ‘Ga’ normal subject during the 
gait cycle 
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difference in anatomy of walking of a PD patient from a healthy subject. Normally, in a normal 
gait the heel strikes the ground first, followed by the toe which is called as heel-to-toe walking. 
Whereas, the PD gait is characterised by a flat foot strike: where the entire foot is planted on the 
ground, simultaneously. Also,   during the later stages the toe touches the ground before the heel, 
called as the toe-to-heel walking [33].  
 
                                                                                                                        
 
 
Additionally, PD patients impart less force at heel strike and it is identified to be related to 
the severity of the disease, with the value of force decreasing as the disease progresses. Also, the 
patients with Parkinson’s disease tend to apply high pressure to the forefoot regions (toe and 
Figure 3.4. The vertical ground reaction force acting on a PD patient from the group ‘Ga’ during 
the gait cycle 
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‘below toe’ areas), in addition to the weight shift near the medial foot regions thus, providing the 
required postural balance [34].    
 
3.3 Gait Detection Algorithm 
In Figure 3.5, the force readings are plotted against time for the left foot of a subject. 
Various gait features are extracted using peak detection and pulse width estimation techniques. 
Also, from the plot points P1-P4 marks one gait cycle and the time period between P1 and P4 
refers to the corresponding stride time. Additionally, time taken to reach from position P1 to P3 is 
the stance period. In the same way, the time taken from point P3 to P4 is called as the swing period. 
Hence, the swing/stance ratio can be calculated from the obtained values. 
                                                                               
 
 
 
 
 
 
Figure 3.5.  Force readings plotted against time for a PD patient’s left foot.  Points P1 to P4 
denotes one gait cycle. Where, P1 is the initial heel contact that marks the beginning of the cycle. 
P2 is the point of contact where maximum force is exerted by the subject. P3 marks the end of 
stance period and start of swing period, where the foot is in the air. P4 points the end of swing 
phase and also the gait cycle. 
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The walking speed of the subject is evaluated by dividing the total distance covered upon 
the total time taken during the testing period. It is typically measured in meters per sec, denoting 
the distance travelled in a second, where the total number of steps is calculated using the peak 
detecting algorithm, which measures the total number of peaks in the plot corresponding to total 
steps taken. Similarly, the total number of steps taken by the right foot can be identified. The sum 
of the steps taken by left and right foot in a minute provides the cadence value. In addition, the 
total distance divided by the total number of steps taken in the covered area gives the average step 
length (time remaining constant).  
 
3.4 Quantification of Tremor 
      Two different types of tremor that occur in humans: the pathological and physiological 
tremor. They have different characteristics (frequency, oscillation) and reason for their 
occurrences. Where, the pathological tremors may occur due to central nervous system and 
peripheral nervous system disorders. The relevant example of a pathological tremor is the 
parkinsonian tremor, which is further classified into rest, postural and kinetic tremors.  To 
elaborate, the rest tremor occurs when the body performs no voluntary action, postural tremor 
occurs while holding a body part such as the arm, leg against gravity without any movement and 
kinetic tremor can be seen when the subject performs any particular task such as finger-to-nose 
test, or writing. However, the PD tremor mostly occurs at rest, oscillating at a frequency of 4-6 Hz 
[35].  
 In comparison to a PD tremor, a physiological tremor (normal tremor) is present in all 
humans. The limb oscillates at a particular resonance frequency that depends on the stiffness of 
the muscle and inertia of the arm. The physiological tremor usually occurs at a frequency of 8-12 
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Hz, and sometimes even higher depending on the position of measurement. So, generally 
physiological tremor is a high freq. component against a pathological tremor, which tends to occur 
at low freq. [35].  
  
 3.4.1 Tremor Features  
 The various tremor features [36, 37] in frequency domain that would help us in detecting 
a PD tremor have been discussed below: 
1) Amplitude:  It is calculated by taking the root mean square (RMS) value of the input 
velocity signal, with the mean subtracted. Amplitude is also the standard deviation of 
the filtered output signal. It is estimated using the power spectral density (PSD) method, 
which plots the power of the signal to the respective frequency. It uses periodogram 
spectrum estimates, which is obtained by converting the time series to a frequency 
domain.   
2) Power distribution: In a typical PD tremor, a large amount of power is concentrated in 
the region between 4-6 Hz contributing to a significant peak in this region. Whereas, 
the normal physiologic tremor is mainly seen in the 8-12 Hz range, also where a high 
proportion of power is observed in the absence of any low-frequency pathological 
tremor (PD tremor).  
3) Frequency dispersion: It measures the width of an interval centered at the median 
frequency that consists of 68% of the spectrum power. In the case of PD, the dispersion 
bandwidth is small as it has a single large peak. Whereas, physiological tremors being 
irregular have several peaks thus, display a wider bandwidth.   
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4) Median frequency: It is the frequency where the power is equally divided between the 
upper and lower parts of the spectrum. While, for power spectrum with a single peak 
the median frequency coincides with this peak for PD subjects.   
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CHAPTER 4: 
DATA ANALYSIS AND RESULTS 
 
4.1 Introduction to Statistical Analysis  
         Various statistical analysis techniques were performed to study the features displayed by a 
PD subject in comparison to a healthy subject. The statistical analysis was done using the Minitab® 
17.2.1 [38] and the results are presented as graphs, plots, and statistical values. Based on the 
statistical analysis, it was observed that the features of the left foot and right foot for all the study 
group subjects were highly correlated. Hence, the force data from only the left foot is presented in 
this thesis for the purpose of discussion. A summary of the data as Mean ± SD (Standard Deviation) 
for the groups ‘Si’, ‘Ju’ and ‘Ga’ are displayed in Tables 4.1, 4.2 and 4.3, respectively. Here, the 
mean of a set of data is defined as the ratio between the summations of all the variables in the 
dataset to the total number of variables in the dataset. The most common measurement of 
variability is the standard deviation (SD), which is typically the distance between any variable in 
the dataset to the average.  
SD =  √
∑ (xi − x̅)2
n
i=1
n − 1
 
where, 𝑥 is any variable in the dataset, ?̅? is the mean and 𝑛 is the total number of variables in the 
dataset. The inter-variability of the features measures the variation between subjects of a group, 
and is calculated by taking the percentage of the ratio between SD and mean of the corresponding 
feature of the group. It provides the coefficient of variability that the subject’s show within a group.                                                                                                                      
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 One-way analysis of variance (ANOVA) test was used to determine if there are any 
significant differences between the mean values of the two groups (PD and normal). The results 
are presented in Tables 4.1, 4.2 and 4.3. The basic model is as follows: 
𝑦𝑎𝑏 = 𝜇 + 𝑇𝑏 + ∈𝑎𝑏 
where, 𝑦𝑎𝑏 is the measured value of observation b in group a, 𝜇 is the mean value, 𝑇𝑏 is the effect 
of an observation in group b, and ∈𝑎𝑏 is the random error. The one-way ANOVA typically tests 
the null hypothesis, which states that there is no significant difference in the mean and are equal 
to each other:   
H0 =  𝜇1 =  𝜇2 =  𝜇3 =   … 𝜇n =  𝜇 
where, 𝜇 is the mean of a group, and n is the number of groups. However, if the result is a 
significant value, i.e., ≤ 0.05 (we are using a 95% confidence interval, therefore α = 0.05), the 
ANOVA rejects the null hypothesis. Then, it accepts the alternative hypothesis (HA),  which 
proves an existence of a significant difference in the mean of the two groups [39, 40].  
 Moreover, a graphical representation of the results is essential in an analysis process, where 
box plots are widely used. A box-plot is a diagrammatic method to summarize the results, and it 
displays the minimum value, lower quartile (bottom 25% of observation), median, upper quartile 
(75% of the observation), and maximum value. Thus, it is useful to study the distribution of the 
different variables from a group and compare them to various groups [39, 40].     
  
4.2 Statistical Analysis Results of Gait Parameters 
 The gait parameters under investigation are the step distance, stride time, stance phase, 
swing phase, heel force, metatarsophalangeal joint (below toe) force, toe force and the normalized 
values of heel, below toe, and toe forces. To reduce the influence of subject’s body weight on the 
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forces, the force values are normalized to the percentage of their body weight using the following 
relation: 
Normalized Force (% body weight) =
Vertical force (N)
Body weight (N)
 X 100% 
 The normalized force value indicates the percentage of body weight a subject utilizes when 
walking. Further, we computed the normalized force percent of the heel, below toe and toe regions 
individually, which can also be helpful to detect the falling symptom in PD patients. In Tables 4.1, 
4.2, and 4.3 statistical results of the test sample from groups ‘Si’, ‘Ju’ and ‘Ga’ are tabulated. It is 
evident from the results that PD patients from all the three groups have shorter average step 
distance, with a slightly higher average stride time than a normal subject. Also, the patients with 
PD have reduced average swing phase compared to normal subjects, and an increase in the average 
stance phase. Moreover, we can notice that the vertical force imparted by the heel region of the 
foot is higher in healthy subjects compared to the PD patients, which also leads to a higher 
normalized heel force in healthy subjects, thus indicating better stability and control.  Since the 
vertical force indicates body control stability, this proves that the normal subjects participated in 
the study had better body control compared to PD patients.  
 The ANOVA results provide us with the most significant gait features and are presented as 
box-plots as shown in Figures 4.1-4.6. The box-plots display the different gait features that have a 
significant difference in its mean value for PD and normal subjects, included for all the three 
groups ‘Si’, ‘Ju’ and ‘Ga’. It also helps to select the features that would yield better classification 
between a PD and healthy subject in the feature selection process. Further, after the significant 
features were obtained through ANOVA test, machine learning was performed to classify the 
subjects based on the patterns exhibited in the dataset.     
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Gait 
Feature 
Normal subject PD subject ANOVA 
p-value ≤ 0.05, 
significant 
difference Mean ± SD Mean ± SD 
Step distance (m) 0.70 ± 0.04 0.58 ± 0.07 < 0.001 
Stride 
time (sec) 
1.05 ± 0.06 1.16 ± 0.08 < 0.001 
Stance phase 
(%) 
64.49 ± 2.35 65.74 ± 2.16 0.088 
Swing phase 
(%) 
34.42 ± 2.51 33.32 ± 2.07 0.141 
Heel force 
(N) 
351.35 ± 83.62 229.03 ± 86.20 < 0.001 
Below toe force (N) 287.92 ± 95.14 295.58 ± 87.71 0.793 
Toe force 
(N) 
171.91 ± 84.35 167.00 ± 72.11 0.844 
Normalized force 
for heel 
(% body weight) 
51.83 ± 11.42 34.79 ± 11.38 < 0.001 
Normalized force 
for  below toe 
(% body weight) 
40.08 ± 10.32 42.93 ± 8.85 0.361 
Normalized force 
for toe 
(% body weight) 
25.67 ± 11.77 25.66 ± 10.04 0.999 
Table 4.1. Mean, standard deviation and p-value for different gait features extracted from group 
‘Si’  
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Gait 
Feature 
Normal subject PD subject ANOVA 
p-value ≤ 0.05, 
significant 
difference Mean ± SD Mean ± SD 
Step distance (m) 0.679 ± 0.06 0.498 ± 0.09 < 0.001 
Stride 
time (sec) 
1.106 ± 0.087 1.131 ± 0.163 0.537 
Stance phase 
(%) 
64.08 ± 1.453 66.61 ± 2.477 < 0.001 
Swing phase 
(%) 
35.90 ± 1.454 33.27 ± 2.741 0.001 
Heel force 
(N) 
348.13 ± 80.30 227.98 ± 88.5 < 0.001 
Below toe force (N) 248.25 ± 50.92 235.38 ± 65.32 0.491 
Toe force 
(N) 
169.27 ± 68.19 173.15 ± 81.71 0.871 
Normalized force 
for heel 
(% body weight) 
52.15 ± 13.79 32.58 ± 12.09 < 0.001 
Normalized force 
for  below toe 
(% body weight) 
36.6 ± 7.25 34.48 ± 10.22 0.454 
Normalized force 
for toe 
(% body weight) 
25.04 ± 9.98 25.88 ± 13.26 0.823 
Table 4.2. Mean, standard deviation and p-value for different gait features extracted from group 
‘Ju’  
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Gait 
Feature 
Normal subject PD subject ANOVA 
p-value ≤ 0.05, 
significant 
difference Mean ± SD Mean ± SD 
Step distance (m) 0.676 ± 0.084 0.467 ± 0.079 < 0.001 
Stride 
time (sec) 
1.127 ± 0.083 1.240 ± 0.269 0.098 
Stance phase 
(%) 
63.66 ± 1.955 69.05 ± 4.481 < 0.001 
Swing phase 
(%) 
35.54 ± 1.894 29.80 ± 4.191 < 0.000 
Heel force 
(N) 
315.0 ± 94.28 230.8 ± 102.1 0.015 
Below toe force (N) 267.8 ± 71.46 249.9 ± 54.68 0.403 
Toe force 
(N) 
187.7 ± 88.36 152.9 ± 51.35 0.157 
Normalized force 
for heel 
(% body weight) 
45.20 ± 12.82 31.77 ± 11.65 0.003 
Normalized force 
for  below toe 
(% body weight) 
41.39 ± 10.13 36.43 ± 10.63 0.173 
Normalized force 
for toe 
(% body weight) 
28.75 ± 12.41 23.03 ± 8.25 0.129 
Table 4.3. Mean, standard deviation and p-value for different gait features extracted from group 
‘Ga’  
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Figure 4.1.  Box plots of average step distance and stride time of PD and normal subjects from 
group ‘Si’, displaying the mean, range, upper and lower quartile of the two parameters. 
Figure 4.2.  Box plots of the average and normalized heel forces of PD and normal subjects from 
group ‘Si’, showing the mean, range, upper and lower quartile of the two parameters. 
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Figure 4.3.  Box plots of average step distance and heel force of PD and normal subjects from 
group ‘Ju’, displaying the mean, range, upper and lower quartile of the two parameters. 
Figure 4.4.  Box plots of stance and swing phases of PD and normal subjects from group ‘Ju’, 
showing the mean, range, upper and lower quartile of the two parameters. 
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Figure 4.5.  Box plots of average step distance and heel force of PD and normal subjects from 
group ‘Ga’, displaying the mean, range, upper and lower quartile of the two parameters. 
Figure 4.6.  Box plots of stance and swing phases of PD and normal subjects from group ‘Ga’, 
showing the mean, range, upper and lower quartile of the two parameters. 
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4.2.1 Comparisons with Current Work 
 In this section, we are comparing our analysis results with the existing benchmark, i.e. 
analysis done by the authors of the physionet database [24]: Frenkel-Toledo et al. [23], Hausdorff 
et al. [25], and Yogev et al. [26]. It is important to note that for our analysis, we had used only the 
data arising from the subjects performing a walking task at their normal, comfortable speed.   
 In the benchmark study, student’s t-test was performed on data to compare the features of 
the healthy and PD subjects. An independent model was applied to each gait parameter, where the 
gait parameter is taken as a dependent variable and their belonging group (PD and healthy) is the 
independent variable. Also, a 95% confidence interval was used, including a p-value of 0.05 as 
significant. Moreover, the extracted gait features include the average gait speed, stride length, 
stride time, and swing time.   
 In Table 4.4, a comparison chart of the statistical summary of the different gait features is 
tabulated between the results from our algorithm versus the benchmark algorithm, for the groups 
‘Si’, ‘Ju’ and ‘Ga’. The results were obtained from the published papers [23, 25 & 26] for study 
purpose only. The gait speed value is taken as a basic reference parameter from the benchmark 
database to calculate other spatiotemporal characteristics. Also, in this work we had calculated the 
step distance of the subjects and not the stride length, as they were proportional to each other. 
However, to perform this comparison, we computed the stride distance value which is the average 
value of the distance between two consecutive points of foot contact of the same feet. As compared 
to our developed algorithm, there is less number of features extracted in the benchmark studies, 
and also our gait feature values are highly correlated to its benchmark. 
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Group   
name 
Gait 
feature 
Benchmark algorithm 
value 
Our algorithm  
value 
Healthy 
subject 
PD subject 
Healthy 
subject 
PD subject 
Mean ± SD Mean ± SD Mean ± SD Mean ± SD 
‘Si’ 
Gait speed 
(m/sec) 
1.24 ± 0.18 1.12 ± 0.15 - - 
Stride 
distance (m) 
1.33 ± 0.11 1.25 ± 0.16 1.41 ± 0.10 1.2 ± 0.12 
Stride time 
(sec) 
1.08 ± 0.09 1.12 ± 0.07 1.05 ± 0.06 1.16 ± 0.08 
Swing time 
(%) 
35.27 ± 1.97 
34.45 ± 
2.60 
34.42 ± 2.51 33.32 ± 2.07 
‘Ju’ 
Gait speed 
(m/sec) 
1.24 ± 0.14 1.00 ± 0.21 - - 
Stride 
distance (m) 
1.35 ± 0.19 1.06 ± 0.21 1.36 ± 0.11 0.99 ± 0.16 
Stride time 
(sec) 
1.08 ± 0.09 1.08 ± 0.13 1.11 ± 0.087 1.13 ± 0.163 
Swing time 
(%) 
36.3 ± 1.4 33.8 ± 3.3 35.90 ± 1.45 33.27 ± 2.74 
‘Ga’ 
Gait speed 
(m/sec) 
1.31 ± 0.19 1.05 ± 0.23 - - 
Stride time 
(sec) 
1.07 ± 0.08 1.08 ± 0.15 1.127 ± 0.083 1.240 ± 0.26 
Swing time 
(%) 
38.03 ± 1.35 
35.57 ± 
2.44 
35.54 ± 1.89 29.80 ± 4.19 
Table 4.4. A comparison between the statistical results of gait features of this paper versus its 
benchmark. 
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4.3 Machine Learning Using LDA  
 In this work, the Linear Discriminant Analysis (LDA) classifier was used to study the 
performance of the extracted gait parameters. The algorithm and its specifications have been 
chosen based on its better performance in comparison to other algorithms. A total of 40 
observations was used for classification purpose, distributed as 20 observations each between PD 
and healthy control subjects. The five-fold cross-validation method was used, that partitions the 
data into five sets or folds. Then for each fold, it trains a model and assesses its performance. 
Further, it calculates the average test error over all the folds. In general, a discriminant function 
takes an input x and assigns it to one of the classes k, denoted as Ck. Also, the decision surface is 
a hyperplane, which is a subspace of one less dimension than the ambient space. The simplest 
linear discriminant is given by [41, 42],  
𝑦(𝑥) =  𝑊𝑇𝑥 +  𝑤0 
 When, y(x) ≥ 0, the input x is assigned to class C1, else C2. In the equation above, term W 
is the weight vector and 𝑤0 is the bias. Moreover, in a standard linear classifier, a considerable 
amount of information is lost due to the overlapping of the data in one dimension. Therefore, we 
used the Fisher’s linear discriminant method to maximize the function to obtain a large separation 
between the class means. Further, it provides a small variance within the class to minimize the 
overlapping problem [41, 42]. While, the intra-class variance of the transformed data from class 
Ck is,  
𝑆𝑘
2 =  ∑ (𝑦𝑛 −  𝑚𝑘)
2
𝑛 ∈𝐶𝑘
 
where, 𝑦𝑛 =  𝑊
𝑇𝑥𝑛 , and 𝑚𝑘 is the mean of class𝐶𝑘. Also, the Fisher’s criteria is defined as the 
ratio of the inter-class variance to the intra-class variance and is given by,  
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𝐽(𝑤) =  
(𝑀2 −  𝑀1)
2 
𝑆1
2 +  𝑆2
2  
 In Figure 4.7, the flow chart of the machine learning process is displayed, which starts by 
extracting the features from the raw data. Then, the extracted features were trained and tested using 
a suitable classifier to obtain the performance of the classifier. Later, the ROC curve for the 
extracted gait features is plotted against the true positive (sensitivity) and false positive (1- 
specificity) rates. In our test, the outcome can be either positive, i.e., presence of PD or negative, 
i.e., absence of PD. In that case, the true positive is the situation where the PD subjects are correctly 
identified with the presence of PD. Then, the false positive denotes that healthy subjects are 
incorrectly identified as PD patients. Further, the accuracy of classification is calculated by finding 
the area under the curve [41, 42].  
 
 
  
 
 
 
 
4.4 LDA Classification Results 
 In Table 4.4, the classification accuracy of the gait parameters for the groups ‘Si’, ‘Ju’, 
‘Ga’ has been tabulated, including the cumulative accuracy of all the gait features combined. The 
rate of accuracy for the average values of the parameters including the step distance, heel force, 
stance phase, and swing phase have outperformed the other features. Hence, these features display 
a substantial difference between the PD and normal groups. 
Figure 4.7. Block diagram of the steps involved in the pattern classification process. ROC: 
receiver operating characteristic. 
Feature extraction Train classifier Testing samples 
Classification 
Accuracy 
ROC curve 
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Gait 
feature 
Classification 
accuracy 
Group “Si” 
(%) 
Classification 
accuracy 
Group “Ju” 
(%) 
Classification 
accuracy 
Group “Ga” 
(%) 
 
Step distance (m) 90.0 92.5 94.4 
Stride 
time (sec) 
77.5 50.0 52.8 
Stance phase 
(%) 
70.0 72.5 77.8 
Swing phase 
(%) 
72.5 70.0 86.1 
Heel force 
(N) 
77.5 77.5 66.7 
Below toe 
force (N) 
27.5 47.5 66.7 
Toe force 
(N) 
30.0 30.0 61.1 
Normalized force 
for heel 
(% body weight) 
77.5 80.0 63.9 
Normalized force 
for  below toe 
(% body weight) 
52.5 50.0 50.0 
Normalized force 
for toe 
(% body weight) 
40.0 27.5 52.8 
Cumulative of all 
the 10 features 
87.5 90.0 83.3 
Table 4.5. A comparison between the classification results of various gait features from the 3 
group subjects. 
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 Moreover, the accuracy rate when all the features were combined is around 87.5% for the 
subjects in group ‘Si’, 90.0% and 83.3% for the subjects in groups ‘Ju’ and ‘Ga’, respectively. We 
decided to group the most distinct features together, and an accuracy rate of 90.0 % was achieved 
for the ‘Si’ group, followed by 92.5% and 92.25% for the ‘Ju’ and ‘Ga’ groups, respectively. On 
the other hand, the remaining less distinguishable features including the normalized forces of the 
heel, below toe and toe, had an accuracy rate of very less significance. 
 In Figure 4.8, we can see the ROC plot between the PD and control subjects utilizing all 
the gait features. An ROC curve plots between the values of true positive rate (sensitivity) to the 
false positive rate (1-specificity). In the plot below, we chose an optimal cut-off point that best 
balances between sensitivity and specificity. For a PD group, the point at which the sensitivity is 
at 0.71 and the specificity is 0.92 is taken as optimal. In a control group, the sensitivity is around 
0.67 for a specificity value of 0.7 is considered to be optimal in this case. We can infer that the 
algorithm performed better in finding a PD from a control subject in comparison to vice-versa. 
Also, around 7 PD patients are diagnosed correctly, for every single misdiagnosis.  
 
 Figure 4.8.  ROC curve plotted using all the gait features for PD and control group. 
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4.5 Tremor Analysis 
 
 The input data is obtained from velocity measurements in the time domain and is further 
converted to digital signal by sampling at 100 Hz. The sampled data taken from [24] consists of 
tremor readings in subjects with PD. In the digitalization process, the input voltage signal (analog) 
is converted to the nearest integer value (digital) by quantization process. As very few information 
can be obtained from the time domain signal, the signal in time domain is transformed to the 
frequency domain. The signal in the frequency domain consists of useful information such as the 
amplitude, frequency and phase [43].  
 The most common and efficient way of converting the time signal to a frequency domain 
is by using the Fast Fourier Transform (FFT). Firstly, the FFT algorithm decomposes the input 
time-signal consisting of N samples to N time domain signals of a sample each. Then, it calculates 
the N frequency spectra w.r.t. the N time domain signals. Finally, all the N spectra are transformed 
into a single frequency spectrum. Moreover, the horizontal axis of the FFT plot decomposes the 
signal into N/2 points, containing only the real part (positive side) of the signal. Further, the 
spectral density describes the amount of signal is present per unit of bandwidth and is also plotted 
to obtain the power of the signal.   In Figure 4.8, the magnitude of the Fourier transformed signal 
is plotted in a single-sided amplitude spectrum.  
 
4.6 Tremor Results 
 From the online database, we utilized the tremor data from PD patients to study the various 
characteristics that could be used to differentiate between a PD tremor and other abnormal tremors.   
So, the tremor characteristics that could significant in providing the distinct characteristics of PD 
tremor are discussed below, 
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4.6.1 Amplitude 
The peak RMS (root mean square) value is defined as the square root of the mean of all the 
input-squared value and is found out to be 0.0749. It is also called as the average mean power of 
the signal, which is useful to compare with other abnormal tremors that typically has a low 
amplitude value.  
 
4.6.2 Power Distribution 
The peak amplitude was measured between the 4-6 Hz interval where a single large peak 
can be seen. In a typical PD tremor, a large amount of power is concentrated in the region between 
4-6 Hz contributing to a significant peak in the region, as seen in Figure 4.9. The amount of power 
distributed in the 4-6 Hz range is 0.0561, i.e., around 91.92% of the total power in the spectrum. 
 
 
  
Figure 4.9.  Plot displaying the FFT output of the input time-domain signal and the amplitude 
of the signal is plotted in a single-sided spectrum. 
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4.6.3 Frequency Dispersion 
In Figure 4.10, the Power Spectral Density (PSD) estimate of the input signal is plotted, 
which displays the distribution of power at various frequencies.  Also, it displays the PSD plot 
before applying windowing technique consisting of spectral leakages. The spectral leakage occurs 
due to an assumption that the input signals are periodic in nature, and it repeats itself corresponding 
to the length of the time value. Various windowing techniques were used to neutralize the effect 
of the spectral leakage. Some of the windows used include the Rectangular (flat-top), Hamming, 
and Hann and are chosen based on the application. In our case, we require a window to enhance 
the frequency resolution and to reduce the spectral leakage, where a Hann window would be ideal 
[43]. Moreover, we measured the dispersed frequency value that consists of 68% of the spectrum 
power. 
 
 
Figure 4.10.  The input signal plotted in a normalized frequency value against the spectral power. 
It also displays the frequency dispersion at 68% of the spectrum power.  
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A typical PD tremor would have a small and narrow dispersion bandwidth as seen in Figure 
4.10. Further, in Figure 4.11 we can see the PSD with a reduced spectral leakage and increased 
resolution, after applying the Hann window of 500 samples length.  
 
4.6.4 Median Frequency 
The median frequency is the point where the power is equally divided between the upper 
and lower parts of the spectrum, was determined to be of value 4.96 Hz. Moreover, from the plot 
it is evident that the median frequency coincides with the single large peak in the spectrum, and a 
similar spectrum is mostly seen in PD subjects.  
 
 Figure 4.11.  The Power Spectral Density (PSD) estimate of the signal using Hann window 
length of 500 samples is displayed. It also specifies the median frequency of the signal. 
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CHAPTER 5: 
CONCLUSION AND FUTURE WORK 
 
5.1 Conclusion 
PD subjects mostly display tremor occurrences and gait impairments during the various 
stages of the disease. An early and accurate diagnosis of PD is required to control the effects of 
the symptoms more efficiently. However, clinical diagnosis of PD might take up to a year and also 
the rate of misdiagnosis is high. 
The purpose of this thesis is to develop a monitoring system for patients with PD using 
wearable sensors.  To achieve that objective, our work focused first on determining the most 
significant gait and tremor features that would best distinguish between PD and normal subjects. 
Various gait features were extracted from the raw data collected from the force sensors to study 
the motor characteristics of PD patients. Then, statistical analysis was performed on the gait 
parameters to recognize the most significant features. Further, LDA classifier was implemented to 
classify the subjects into two groups (PD and healthy).  From the results, it was observed that gait 
features such as step distance, heel force, stance and swing phases provide better performance 
(feature discrimination) than other feature parameters.  An average accuracy rate of 86.9 % 
between a PD patient and normal subject was obtained.  Similarly, tremor analysis was conducted 
on the tremor input data, where we extracted the frequency-domain characteristics of the signal: 
amplitude, power distribution, frequency dispersion, and median frequency to identify a PD tremor
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from the artifacts. This research can be supplemental to the clinical evaluation in accurately 
diagnosing PD at its onset. 
 
5.2 Recommendations for Future Research 
The eventual goal is to acquire real-time clinical data by conducting the gait and tremor 
experiments on PD and healthy subjects, for a better analysis and classification results.  Further, 
the plan is to integrate the tremor and gait monitoring system for an early, accurate diagnosis of 
PD. Also, from the study it is evident that both the gait and tremor features are critical in diagnosing 
PD. So, an integrated system will be operating as a logic ‘OR’ gate, where a high output (presence 
of PD) appears if one or both of the gate inputs (gait and tremor features) are high. If neither input 
is high, it results in a low output (absence of PD). Additionally, more distinguishable features 
would be obtained including the kinematic gait parameters (joint angles), and inter-variability of 
gait features to provide better performance in separating a PD from a healthy subject.  
Next, the developed algorithm would be utilized to extract different gait and tremor 
features from the real–time clinical data. After extracting the features, the data would be trained 
using a suitable model and tested for accuracy. Then, a random or a new patient’s data would be 
used to perform the testing, and the algorithm is expected to have the ability to identify the subject 
as either PD or normal subject that many percentage of times as the accuracy of the model. So, 
typically the percentage of accuracy denotes the successful rate of the algorithm in predicting the 
subject’s group or class. 
    Later, our focus is to utilize other feature selection methods such as the principal 
component analysis (PCA) as a model to study the individual performances of the feature and also 
to select the most significant features from the others. It would provide us with a high accuracy of 
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classification and thus, increase the chances of distinguishing a PD from a non-PD subject. Finally, 
we would look into the possibility of monitoring the occurrences of dyskinesia that occurs during 
the ‘wearing off’ period of medications. It could help the doctors and patients to understand their 
pattern of occurrence better and hence manage them more efficiently. 
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APPENDIX A: EXTRACTED GAIT FEATURES 
 
Table A1. The gait features extracted from the group ‘Si’ subjects are tabulated. 
Subject 
no. 
Type 
H&Y 
stage 
Avg. heel 
force (N) 
Avg. 
below toe 
force (N) 
Avg. toe 
force (N) 
BW % 
(heel) 
BW % 
(below 
toe) 
BW % 
(toe) 
Avg. 
step dist. 
(m) 
Stance 
% 
Swing 
% 
Avg. 
stride time 
(sec) 
SiPt02 PD 2.5 247.71 211.93 231.49 39.04 38.41 40.33 0.43 69.57 30.25 1.11 
SiPt29 PD 2.5 157.49 322.05 99.93 24.05 40.83 11.62 0.54 68.34 31.16 1.32 
SiPt39 PD 2 301.96 171.73 60.89 54.45 42.61 15.63 0.47 68.38 31.08 1.07 
SiPt31 PD 2 45.13 244.8 164.69 12.88 38.02 23.9 0.51 68.51 30.62 1.14 
SiPt10 PD 2 199.95 282.59 203.71 33.51 48.94 31.92 0.56 64.02 35.24 1.23 
SiPt36 PD 2 98.01 282.02 124.27 25.71 58.46 24.96 0.51 65.79 33.01 1.06 
SiPt12 PD 2 220.59 258.96 201.1 45.86 41.62 39.09 0.59 63.74 35.46 1.21 
SiPt37 PD 2.5 187.16 338.83 193.56 28.65 44.41 34.88 0.61 67.26 31.86 1.26 
SiPt22 PD 2 328.31 190.19 115.54 51.36 30.45 25.82 0.55 68.27 30.93 1.11 
SiPt15 PD 2 126.86 333.3 198.31 22.19 39.22 24.97 0.56 65.63 32.97 1.08 
SiPt20 PD 2 338.81 243.95 119.07 50.03 36.64 20.27 0.63 61.76 36.71 1.25 
SiPt38 PD 2 205.46 227.96 125.58 32.27 30.52 19.21 0.62 65.65 33.54 1.16 
SiPt40 PD 2.5 327.48 451.07 123.16 35.69 52.12 14.01 0.53 66.56 32.26 1.01 
SiPt33 PD 2 221.24 462.05 116.79 30.47 57.31 17.22 0.61 63.43 35.92 1.14 
SiPt07 PD 2 187.11 273.68 340.12 27.82 41.08 46.11 0.63 64.33 34.86 1.17 
SiPt23 PD 2 266.99 274.71 111.36 34.22 34.81 13.27 0.61 62.61 37.28 1.11 
SiPt13 PD 2 258.1 487.07 210.68 29.17 61.77 29.14 0.59 66.04 32.85 1.08 
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Subject 
no. 
Type 
H&Y 
stage 
Avg. heel 
force (N) 
Avg. 
below toe 
force (N) 
Avg. toe 
force (N) 
BW % 
(heel) 
BW % 
(below 
toe) 
BW % 
(toe) 
Avg. 
step dist. 
(m) 
Stance 
% 
Swing 
% 
Avg. 
stride 
time (sec) 
SiPt18 PD 2 186.53 290.19 177.89 24.01 35.45 21.55 0.69 65.95 32.81 1.24 
SiPt32 PD 2 385.57 342.92 317.68 50.43 46.56 39.28 0.7 64.96 33.29 1.26 
SiPt16 PD 2 290.15 221.54 104.22 44.07 39.49 20.17 0.67 64.15 34.46 1.2 
SiCo12 Control 0 450.57 241.91 306.57 80.81 42.47 49.19 0.71 65.15 33.97 0.92 
SiCo15 Control 0 257.52 215.29 79.27 40.33 26.03 10.82 0.79 66.99 32 1.04 
SiCo11 Control 0 500.03 433.41 380.91 63.02 56.33 41.11 0.68 63.76 35.58 0.91 
SiCo21 Control 0 333.01 396.81 248.35 37.14 39.84 29.81 0.77 64.97 33.77 1.06 
SiCo10 Control 0 397.46 227.15 68.66 57.97 29.64 14.97 0.7 63.04 36.56 0.98 
SiCo04 Control 0 357.2 236.51 59.08 53.18 37.24 10.31 0.75 62.52 35.82 1.06 
SiCo30 Control 0 461.09 413.05 156.59 57.29 53.66 20.39 0.75 64.53 34.92 1.06 
SiCo22 Control 0 413.27 453.04 224.38 49.88 44.62 21.21 0.71 63.94 34.35 1.01 
SiCo03 Control 0 317.34 147.05 142.02 52.89 32.34 25.36 0.71 62.35 36.18 1.05 
SiCo07 Control 0 156.01 302.87 265.91 26.52 52.51 46.19 0.71 62.26 36.95 1.05 
SiCo09 Control 0 372.57 154.51 149.72 51.73 26.54 20.79 0.71 63.38 35.91 1.09 
SiCo13 Control 0 337.92 400.85 173.11 56.15 53.39 25.82 0.69 63.81 35.07 1.06 
SiCo29 Control 0 376.75 232.11 87.49 48.49 33.49 14.38 0.67 63.11 35.56 1.05 
SiCo18 Control 0 229.61 336.22 242.37 46.31 55.79 43.92 0.69 64.11 34.81 1.11 
SiCo06 Control 0 353.83 205.12 124.9 64.64 38.31 28.03 0.67 62.74 35.89 1.06 
SiCo20 Control 0 406.91 330.87 169.54 45.79 40.11 23.18 0.7 66.42 32.02 1.13 
SiCo17 Control 0 232.82 311.07 168.52 N/A N/A N/A 0.66 65.16 33.68 1.1 
SiCo08 Control 0 332.04 157.81 150.41 48.7 24.49 22.58 0.63 64.32 35.16 1.01 
SiCo23 Control 0 375.57 283.21 153.59 47.02 35.71 25.85 0.65 64.5 34.99 1.12 
SiCo14 Control 0 365.41 279.6 86.88 57.02 39.17 13.83 0.65 72.9 25.32 1.14 
Table A1. (Continued) 
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Subject 
no. 
Type 
H&Y 
stage 
Avg. heel 
force (N) 
Avg. 
below toe 
force (N) 
Avg. toe 
force (N) 
BW % 
(heel) 
BW % 
(below 
toe) 
BW % 
(toe) 
Avg. 
step dist. 
(m) 
Stance 
% 
Swing 
% 
Avg. stride 
time (sec) 
JuPt18 PD 3 61.46 253.26 192.74 9.63 39.71 30.22 0.306 69.31 30.68 1.67 
JuPt21 PD 2.5 266.06 262.58 76.06 36.16 35.68 10.33 0.379 71.56 26.25 1.31 
JuPt13 PD 3 35.06 257.04 151.31 5.95 43.67 25.71 0.354 69.66 30.33 1.17 
JuPt16 PD 2 220.19 290.92 244.37 35.62 47.07 39.54 0.44 64.29 35.71 1.24 
JuPt11 PD 2 278.28 205.78 57.33 35.45 26.22 7.3 0.386 67.92 32.07 0.99 
JuPt04 PD 2.5 149.38 351.54 112.79 19.03 44.79 14.37 0.428 68.55 31.44 1.07 
JuPt10 PD 3 317.94 131.47 295.69 40.51 16.75 37.67 0.63 67.1 32.89 1.08 
JuPt02 PD 2.5 196.04 161.57 112.53 29.38 24.22 16.86 0.47 68.35 31.64 1.04 
JuPt14 PD 2 114.56 155.25 138.25 18.53 25.12 22.37 0.581 67.57 32.42 1.28 
JuPt24 PD 2.5 320.79 234.07 96.97 43.6 31.81 13.18 0.48 66.66 33.33 1.09 
JuPt26 PD 2 231.83 322.58 61.69 28.13 39.14 7.48 0.54 65.3 34.69 1.18 
JuPt03 PD 2.5 205.93 231.84 173.92 32.29 36.35 27.27 0.54 65.75 34.24 1.17 
JuPt01 PD 2 307.01 269.3 144.05 36.81 32.29 17.27 0.55 63.79 36.2 1.11 
JuPt29 PD 2.5 145.82 294.14 214.11 24.36 49.15 35.78 0.54 64.87 35.12 1.08 
JuPt12 PD 2.5 231.12 217.51 277.31 42.07 39.59 50.47 0.53 68.51 31.48 1.06 
JuPt25 PD 2 231.33 312.86 137.61 34.67 46.89 20.62 0.609 65.87 34.12 1.12 
JuPt28 PD 2.5 177.21 424.14 245.74 27.79 66.51 38.53 0.59 66.92 33.07 1.08 
JuPt07 PD 3 319.21 265.63 266.18 50.06 41.65 41.74 0.48 63.83 36.16 0.87 
JuPt15 PD 2.5 330.58 217.48 295.73 51.05 33.59 45.67 0.53 65.41 34.58 0.99 
JuPt17 PD 2.5 279.06 141.41 118.65 37.92 19.21 16.12 0.57 60.83 39.16 1.03 
Table A2. The gait features extracted from the group ‘Ju’ subjects are tabulated. 
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Subject 
no. 
Type 
H&Y 
stage 
Avg. heel 
force (N) 
Avg. 
below toe 
force (N) 
Avg. toe 
force (N) 
BW % 
(heel) 
BW % 
(below 
toe) 
BW % 
(toe) 
Avg. 
step dist. 
(m) 
Stance 
% 
Swing 
% 
Avg. stride 
time (sec) 
JuCo17 Control 0 399.21 232.18 239.69 67.82 39.44 40.72 0.811 62.95 37.04 1.07 
JuCo16 Control 0 465.81 212.32 141.05 57.21 26.07 17.32 0.69 62.64 37.35 0.98 
JuCo14 Control 0 329.99 333.09 231.63 37.37 37.72 26.23 0.75 66.4 33.59 1.095 
JuCo24 Control 0 229.51 270.12 165.21 32.49 38.24 23.39 0.71 62.28 37.71 1.05 
JuCo26 Control 0 307.01 269.3 144.05 44.71 39.21 20.97 0.73 63.79 36.2 1.11 
JuCo07 Control 0 351.71 208.98 216.28 61.81 36.73 38.01 0.62 64.54 35.45 0.97 
JuCo02 Control 0 400.24 309.61 58.73 50.99 39.45 7.48 0.67 65.91 34.08 1.06 
JuCo03 Control 0 344.82 234.26 213.65 58.58 39.81 36.29 0.61 63.12 36.87 1.01 
JuCo08 Control 0 440.02 216.92 162.64 69.01 34.01 25.51 0.65 66.09 33.9 1.087 
JuCo25 Control 0 472.26 271.62 322.91 56.63 32.57 38.72 0.77 64.33 35.66 1.276 
JuCo19 Control 0 336.01 198.74 115.95 58.05 34.33 20.03 0.649 64.18 35.81 1.07 
JuCo05 Control 0 285.76 141.84 125.73 56.01 27.81 24.64 0.66 62.39 37.6 1.13 
JuCo04 Control 0 357.59 247.15 185.38 45.56 31.49 23.62 0.65 65.39 34.61 1.09 
JuCo18 Control 0 347.72 274.48 107.51 60.07 47.42 18.57 0.63 64.73 35.26 1.09 
JuCo11 Control 0 150.45 283.54 152.6 21.91 41.29 22.22 0.71 61.51 38.49 1.19 
JuCo13 Control 0 406.41 235.35 95.21 57.53 33.32 13.47 0.632 63.97 36.02 1.14 
JuCo23 Control 0 228.96 304.19 245.21 26.82 35.64 28.73 0.77 62.29 37.7 1.34 
JuCo15 Control 0 391.75 316.91 230.1 71.31 57.68 41.88 0.63 64.68 35.31 1.123 
JuCo22 Control 0 343.81 250.21 180.16 46.72 34.01 24.48 0.63 66.13 33.86 1.128 
JuCo12 Control 0 373.61 154.26 51.63 62.43 25.77 8.62 0.614 64.41 35.58 1.11 
Table A2. (Continued) 
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Subject 
no. 
Type 
H&Y 
stage 
Avg. heel 
force (N) 
Avg. 
below toe 
force (N) 
Avg. toe 
force (N) 
BW % 
(heel) 
BW % 
(below 
toe) 
BW % 
(toe) 
Avg. 
step dist. 
(m) 
Stance 
% 
Swing 
% 
Avg. stride 
time (sec) 
GaPt03 PD 3 71.97 208.56 155.25 19.84 42.64 28.08 N/A 71.69 27.86 1.995 
GaPt07 PD 3 63.33 189.99 109.75 11.3 38.61 25.62 0.455 75.91 23.63 1.52 
GaPt09 PD 3 279.89 272.97 98.7 39.96 39.19 18.68 0.444 65.91 31.42 1.014 
GaPt17 PD 3 265.36 273.11 128.82 32.89 25.71 18.97 0.425 67.71 31.74 1.169 
GaPt21 PD 3 202.13 197.86 166.67 31.86 36.14 26.18 0.59 63.01 33.24 1.039 
GaPt23 PD 3 284.83 199.43 105.94 N/A N/A N/A 0.26 80.02 19.37 1.749 
GaPt04 PD 2.5 264.35 261.83 116.29 N/A N/A N/A 0.413 70.09 29.69 1.395 
GaPt05 PD 2.5 201.28 348.67 240.59 38.77 66.01 45.6 0.489 64.81 34.46 1.083 
GaPt25 PD 2.5 398.1 209.35 303.8 47.89 20.8 26.97 0.553 69.43 28.14 1.00 
GaPt28 PD 2.5 168.89 333.43 158.61 19.95 34.19 16.86 0.546 70.18 28.13 1.131 
GaPt31 PD 2.5 394.49 247.88 129.73 41.65 32.25 10.59 0.484 68.97 30.18 1.14 
GaPt33 PD 2.5 257.87 255.53 160.11 36.42 24.92 25.03 0.51 73.07 26.03 1.274 
GaPt20 PD 2 191.77 167.05 145.09 25.04 32.65 14.6 0.405 67.37 31.32 1.152 
GaPt13 PD 2 119.27 239.09 163.09 25.08 48.88 30.36 0.363 72.88 26.15 0.988 
GaPt22 PD 2 266.43 233.59 131.71 41.63 37.15 19.56 0.498 62.59 36.1 1.254 
GaPt06 PD 2 374.43 365.49 116.43 44.35 41.11 15.19 0.489 67.74 31.64 1.158 
GaPt18 PD 2 255.82 250.25 125.19 40.35 29.09 19.56 0.51 65.76 33.57 1.146 
GaPt15 PD 2 93.54 243.58 196.61 11.28 33.55 26.67 0.517 65.83 33.7 1.107 
Table A3. The gait features extracted from the group ‘Ga’ subjects are tabulated. 
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Subject 
no. 
Type 
H&Y 
stage 
Avg. heel 
force (N) 
Avg. 
below toe 
force (N) 
Avg. toe 
force (N) 
BW % 
(heel) 
BW % 
(below 
toe) 
BW % 
(toe) 
Avg. 
step dist. 
(m) 
Stance 
% 
Swing 
% 
Avg. stride 
time (sec) 
GaCo04 Control 0 214.57 369.92 126.89 35.49 56.93 28.69 0.734 62.92 35.75 1.254 
GaCo11 Control 0 438.95 250.78 52.17 55.66 35.7 8.23 0.768 66.89 32.49 1.035 
GaCo12 Control 0 304.22 175.94 117.79 49.81 35.76 23.83 0.698 61.81 34.28 1.025 
GaCo15 Control 0 294.14 350.11 244.38 38.68 53.76 42.01 0.711 62.09 37.01 1.059 
GaCo16 Control 0 294.37 249.15 224.38 45.4 41 37.31 0.715 66.43 33.15 1.077 
GaCo17 Control 0 409.31 275.85 138.11 73.29 43.82 29.17 0.79 60.28 38.74 1.121 
GaCo22 Control 0 246.55 298.28 173.89 43.83 40.95 25.42 0.838 65.46 33.31 1.104 
GaCo14 Control 0 282.84 283.37 159.5 66.04 58.07 39.33 0.735 60.8 38.13 1.124 
GaCo07 Control 0 545.2 221.03 116.82 51.66 30.93 10.51 0.672 63.97 35 1.087 
GaCo09 Control 0 241.08 255.35 388.52 41.14 39.55 52.29 0.663 63.48 35.94 1.079 
GaCo13 Control 0 333.85 252.81 134.23 48.17 38.89 17.77 0.614 65 34.55 1.008 
GaCo10 Control 0 348.82 261.45 281.84 45.66 49.85 39.21 0.624 63.16 36.42 1.071 
GaCo06 Control 0 151.76 352.56 263.49 18.01 46.34 34.35 0.653 61.53 36.96 1.167 
GaCo01 Control 0 376.97 341.94 122.05 47.45 44.74 18.24 0.657 62.61 35.94 1.262 
GaCo03 Control 0 374.63 301.56 173.96 39.84 30.28 20.01 0.653 66.24 33.45 1.277 
GaCo02 Control 0 353.45 108.08 103.5 51.22 21.56 16.67 0.578 65.19 34 1.156 
GaCo08 Control 0 236.96 324.04 337.01 35 49.44 46.63 0.593 63.5 36.02 1.23 
GaCo05 Control 0 222.72 148.68 220.64 27.31 27.45 27.8 0.482 64.51 38.52 1.141 
Table A3. (Continued) 
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